Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epileptic Syndromes”

434 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 434 results

Not applicableStudy completedNCT00361010
What this trial is testing

A Pilot Study of Efficacy and Tolerability of Levetiracetam Monotherapy in Subjects With Childhood Absence Epilepsy

Who this might be right for
EpilepsyChildhood Absence EpilepsySeizures
The Cleveland Clinic 20
Not applicableNot Yet RecruitingNCT07434986
What this trial is testing

Overnight TI in TLE

Who this might be right for
Temporal Lobe Epilepsy (TLE)Drug Resistant EpilepsySleep
Duke University 20
Testing effectiveness (Phase 2)Looking for participantsNCT05104983
What this trial is testing

Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study

Who this might be right for
Tuberous Sclerosis ComplexEpilepsy
Darcy Krueger 64
Large-scale testing (Phase 3)Looking for participantsNCT06315322
What this trial is testing

Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence Epilepsy or Juvenile Absence Epilepsy

Who this might be right for
Childhood Absence EpilepsyJuvenile Absence Epilepsy
UCB Biopharma SRL 120
Not applicableStudy completedNCT03857451
What this trial is testing

Treatment of Gait Disorders in Children With Dravet Syndrome

Who this might be right for
Dravet SyndromeSevere Myoclonic Epilepsy of Infancy
Universiteit Antwerpen 50
Large-scale testing (Phase 3)WithdrawnNCT02174094
What this trial is testing

Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome

Who this might be right for
Dravet Syndrome
H. Lundbeck A/S
Not applicableWithdrawnNCT02913742
What this trial is testing

The Utility of NIOM During LITT for Refractory MTLE

Who this might be right for
Epilepsy, Temporal Lobe
Duke University
Testing effectiveness (Phase 2)Study completedNCT03181399
What this trial is testing

Diet Treatment Glucose Transporter Type 1 Deficiency (G1D)

Who this might be right for
GLUT1DS1EpilepsyGlut1 Deficiency Syndrome 1, Autosomal Recessive+4 more
University of Texas Southwestern Medical Center 45
Not applicableStudy completedNCT04653571
What this trial is testing

CASPR2 Encephalitis Initial Symptoms

Who this might be right for
CASPR2-AntibodyEncephalitis AutoimmuneParaneoplastic Syndromes
Hospices Civils de Lyon 48
Post-approval studies (Phase 4)Ended earlyNCT02090998
What this trial is testing

Sphenopalatine Ganglion Nerve Block vs. Elavil for Treatment of Transformed Migraines

Who this might be right for
Transformed MigraineChronic Daily Headache
Rutgers, The State University of New Jersey 10
Large-scale testing (Phase 3)WithdrawnNCT02318563
What this trial is testing

Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Dravet Syndrome

Who this might be right for
Dravet Syndrome
INSYS Therapeutics Inc
Not applicableStudy completedNCT02844465
What this trial is testing

Stereotactic Laser Ablation for Temporal Lobe Epilepsy (Slate)

Who this might be right for
Temporal Lobe Epilepsy
MedtronicNeuro 167
Not applicableStudy completedNCT02946151
What this trial is testing

Subcutaneous EEG in Epilepsy

Who this might be right for
Temporal Lobe Epilepsy
Zealand University Hospital 10
Large-scale testing (Phase 3)Study completedNCT02091375
What this trial is testing

Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1)

Who this might be right for
EpilepsyDravet Syndrome
Jazz Pharmaceuticals 120
Large-scale testing (Phase 3)Study completedNCT01151540
What this trial is testing

A Long Term Extension Study of E2080 in Lennox-Gastaut Patients

Who this might be right for
Lennox-Gastaut Syndrome
Eisai Co., Ltd. 54
Not applicableStudy completedNCT03094793
What this trial is testing

Impact of Interictal Electroencephalographic Abnormalities on the Stability of Attention in the Epilepsies

Who this might be right for
Epilepsy
University Hospital, Grenoble 162
Testing effectiveness (Phase 2)Looking for participantsNCT06401538
What this trial is testing

BMB-101 in Absence Epilepsy and DEE

Who this might be right for
Absence EpilepsyJeavons SyndromeDravet Syndrome+1 more
Bright Minds Biosciences Pty Ltd 20
Large-scale testing (Phase 3)Ended earlyNCT01668654
What this trial is testing

Long-term, Open-label Safety Extension Study of Retigabine/Ezogabine in Pediatric Subjects (>= 12 Years Old) With POS or LGS

Who this might be right for
Epilepsy
GlaxoSmithKline 4
Testing effectiveness (Phase 2)Ended earlyNCT01281956
What this trial is testing

PRX-00023 Therapy in Localization-Related Epilepsy

Who this might be right for
EpilepsyEpilepsy, Temporal LobePartial Epilepsy
National Institute of Neurological Disorders and Stroke (NINDS) 12
Early research (Phase 1)Study completedNCT02286986
What this trial is testing

Cannabidiol (CBD) to 27 Patients (Aged 2 Years - 19 Years) With Drug Resistant Epilepsy

Who this might be right for
Epilepsy
University of Utah 26
Load More Results